Botulinum Toxin Reduces Dysphagia in Patients With Nonachalasia Primary Esophageal Motility Disorders

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 9, 2013, Pages 1115-1121.e2

  Vanuytsel, Tim ^a,b   Bisschops, Raf ^b   Farré, Ricard ^a   Pauwels, Ans ^a   Holvoet, Lieselot ^b   Arts, Joris ^b   Caenepeel, Philip ^b   De Wulf, Dominiek ^b   Mimidis, Kostas ^b   Rommel, Nathalie ^a   Tack, Jan ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Botox; Diffuse Esophageal Spasm; Hypercontractile Esophagus; Hypertensive; Jackhammer Esophagus

Indexed keywords

BOTULINUM TOXIN A; SODIUM CHLORIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPHAGIA; ESOPHAGUS ACHALASIA; ESOPHAGUS DISEASE; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; ESOPHAGUS PRESSURE; ESOPHAGUS SPASM; HEARTBURN; HUMAN; LIQUID; LOWER ESOPHAGUS SPHINCTER; MOTOR DYSFUNCTION; NUTCRACKER ESOPHAGUS; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOLID; TERTIARY HEALTH CARE; THORAX PAIN; WEIGHT REDUCTION;

BOTOX; BOTULINUM TOXIN A; BTX; DCI; DES; DIFFUSE ESOPHAGEAL SPASM; DISTAL CONTRACTILE INTEGRAL; EGJ; ESOPHAGOGASTRIC JUNCTION; HIGH-RESOLUTION MANOMETRY; HRM; HYPERCONTRACTILE ESOPHAGUS; HYPERTENSIVE; JACKHAMMER ESOPHAGUS; LES; LOWER ESOPHAGEAL SPHINCTER; NE; NUTCRACKER ESOPHAGUS;

ADULT; AGED; BOTULINUM TOXINS; DEGLUTITION DISORDERS; DOUBLE-BLIND METHOD; ENDOSCOPY; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGEAL SPASM, DIFFUSE; FEMALE; HUMANS; MALE; MANOMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84882793667     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.03.021     Document Type: Article

References (20)

1. Fass R., Navarro-Rodriguez T. Noncardiac chest pain. J Clin Gastroenterol 2008, 42:636-646.
2. Spechler S.J., Castell D.O. Classification of oesophageal motility abnormalities. Gut 2001, 49:145-151.
3. Pandolfino J.E., Kahrilas P.J. AGA technical review on the clinical use of esophageal manometry. Gastroenterology 2005, 128:209-224. American Gastroenterological Association.
4. Eckardt A.J., Eckardt V.F. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol 2011, 8:311-319.
5. Hulselmans M., Vanuytsel T., Degreef T., et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 2010, 8:30-35.
6. Boeckxstaens G.E., Annese V., des Varannes S.B., et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med 2011, 364:1807-1816.
7. Tutuian R., Castell D.O. Review article: oesophageal spasm - diagnosis and management. Aliment Pharmacol Ther 2006, 23:1393-1402.
8. Bashashati M., Andrews C., Ghosh S., et al. Botulinum toxin in the treatment of diffuse esophageal spasm. Dis Esophagus 2010, 23:554-560.
9. Grübel C., Borovicka J., Schwizer W., et al. Diffuse esophageal spasm. Am J Gastroenterol 2008, 103:450-457.
10. Fornari F., Bravi I., Penagini R., et al. Multiple rapid swallowing: a complementary test during standard oesophageal manometry. Neurogastroenterol Motil 2009, 21. 718-e41.
11. Pandolfino J.E., Ghosh S.K., Rice J., et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol 2008, 103:27-37.
12. Kahrilas P.J., Ghosh S.K., Pandolfino J.E. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol 2008, 42:627-635.
13. Bredenoord A.J., Fox M., Kahrilas P.J., et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil 2012, 24(Suppl 1):57-65.
14. Vantrappen G., Hellemans J. Treatment of achalasia and related motor disorders. Gastroenterology 1980, 79:144-154.
15. Miller L.S., Parkman H.P., Schiano T.D., et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996, 41:2025-2031.
16. Nebendahl J.C., von Schrenck T., Matsui U., et al. Treatment of diffuse esophageal spasm with botulinum toxin: a prospective study with 6 month follow up. Gastroenterology 1999, 116:A802.
17. Storr M., Roesch T., Born P., et al. Long-term treatment of symptomatic diffuse esophageal spasm by injection of botulinum toxin (BTX). Gastroenterology 2003, 124:A237.
18. Storr M., Allescher H.D., Rösch T., et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 2001, 54:754-759.
19. Miller L.S., Pullela S.V., Parkman H.P., et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002, 97:1640-1646.
20. Barham C.P., Gotley D.C., Fowler A., et al. Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry. Gut 1997, 41:151-155.